Trial Profile
Phase II Study With Rituximab and CHOP in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Diffuse large B cell lymphoma; Gastric cancer
- Focus Therapeutic Use
- 19 Oct 2008 Actual patient number (30) added as reported by ClinicalTrials.gov.
- 19 Oct 2008 Status changed from recruiting to completed.
- 19 Oct 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.